Health · 1 views

FDA approves another over-the-counter naloxone nasal spray

The U.S. Food and Drug Administration has approved another over-the-counter intranasal naloxone product, Rextovy (naloxone hydrochloride)…

Source Medical Xpress AI Summary Updated 2h 37m ago

Story intelligence Beta

Freshness Fresh Updated 2h 37m ago

Confidence Limited Single-outlet story

Coverage Single outlet

Views 1 Community interest

Read time 1 min ~31 words

AI Summary

The U.S. Food and Drug Administration has approved another over-the-counter intranasal naloxone product, Rextovy (naloxone hydrochloride), for the emergency treatment of opioid overdose. The nonprescription approval was granted to Amphastar Pharmaceuticals.

Read full article on Medicalxpress

AI summaries can be wrong sometimes—always verify important details using the source article.